SEEKYO Competitors and Similar CompaniesClear all

IO Biotech's competitors and similar companies include Cullgen, AgomAb Therapeutics and Arcellx.
IO Biotech
IO Biotech
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
Cullgen
Cullgen
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
AgomAb Therapeutics
AgomAb Therapeutics
AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.
Arcellx
Arcellx
Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.
Founding Date
Founding Date
2014
Founding Date
2018
Founding Date
2017
Founding Date
2015
Type
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
København, DK
Usk, GB
Rockville, US
Locations
San Diego, US HQ
Shanghai, CN
Tokyo, JP
Locations
Antwerpen, BE HQ
Gent, BE
Locations
Gaithersburg, US HQ
Employees
Employees
19
Employees
4
Employees
62
Employees
78
Valuation ($)
Valuation ($)
85.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
4.7 b

Financial

Net income
Net income
($95.5m) (FY, 2024)
Net income
N/A
Net income
N/A
Net income
($228.9m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 165.9m
Total funding raised
$ 31m
Total funding raised
$ 97.6m
Total funding raised
$ 200m
For sources of this data, please see the company profile

View Company Profiles

Cullgen
HQ
San Diego, US
Employees
4

Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.

View company
AgomAb Therapeutics
HQ
Antwerpen, BE
Employees
62

AgomAb Therapeutics is a biotherapeutics company developing molecular therapies for the regeneration of damaged tissues.

View company
Arcellx
HQ
Gaithersburg, US
Employees
78

Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.

View company